Classification of HHV-6A and HHV-6B as distinct viruses
Dharam V. Ablashi(HHV-6 Foundation), Tetsushi Yoshikawa(Fujita Health University), Mario Luppi(University of Modena and Reggio Emilia), Joshua C. Pritchett(HHV-6 Foundation), Roberto Álvarez‐Lafuente(Hospital Clínico San Carlos), Peter G. Medveczky(University of South Florida), Mauro Malnati, Paolo Lusso(National Institute of Allergy and Infectious Diseases), Steven Jacobson(National Institutes of Health), Yasuko Mori(Kobe University), Per Höllsberg(Aarhus University Hospital), Philip E. Pellett(Wayne State University), Stephen Dewhurst(University of Rochester Medical Center), Duncan A. Clark(Barts Health NHS Trust), Henri Agut, Louis Flamand(Centre hospitalier universitaire de Québec), Dario Di Luca(University of Ferrara), Koichi Yamanishi(The University of Osaka), Ursula A. Gompels(University of London), Niza Frenkel(Tel Aviv University), Robert C. Gallo(National Institutes of Health)
Cited by 360
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
|Blood|2011|460
A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection
|Annals of Internal Medicine|1992|391